Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma

NCT02428764 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients enrolled.

Conditions

Lung Cancer

Interventions

DRUG: Nimotuzumab
DRUG: Gemcitabine
DRUG: Carboplatin
PROCEDURE: Surgery

Sponsor

Sun Yat-sen University